#fda pfizer vaccine 5-11
FDA Advisory Committee Backs Pfizer Vaccine in 5-11 Year-olds
This marks the start of the authorization process, with formal backing still needed by the FDA. The process continues on Nov. 2 and 3, when an advisory committee with the Centers for Disease Control and Prevention is scheduled to meet to discuss clinical recommendations.
